Cargando…

Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. The interplay between the virus and host innate and adaptive immune responses determines the outcome of infection. There is increasing evidence that host neutralizing responses play a relevant role in the resultin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fafi-Kremer, Samira, Fauvelle, Catherine, Felmlee, Daniel J., Zeisel, Mirjam B., Lepiller, Quentin, Fofana, Isabel, Heydmann, Laura, Stoll-Keller, Françoise, Baumert, Thomas F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497039/ https://www.ncbi.nlm.nih.gov/pubmed/23202451 http://dx.doi.org/10.3390/v4102016

Ejemplares similares

Adaptive Immunity to Hepatitis C Virus
por: Zeisel, Mirjam B., et al.
Publicado: (2009)

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
por: Fafi-Kremer, Samira, et al.
Publicado: (2010)

Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents
por: Xiao, Fei, et al.
Publicado: (2014)

Genotype 1 Hepatitis C Virus Envelope Features That Determine Antiviral Response Assessed through Optimal Covariance Networks
por: Murray, John M., et al.
Publicado: (2013)

A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission
por: Fofana, Isabel, et al.
Publicado: (2013)

Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease
por: Felmlee, Daniel J., et al.
Publicado: (2013)

Microcephaly Caused by Lymphocytic Choriomeningitis Virus
por: Delaine, Maia, et al.
Publicado: (2017)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015)

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape
por: Colpitts, Che C, et al.
Publicado: (2018)

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies
por: Duong, Francois H.T., et al.
Publicado: (2014)

Host-targeting therapies for hepatitis C virus infection: current developments and future applications
por: Crouchet, Emilie, et al.
Publicado: (2018)

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection
por: Verrier, Eloi R., et al.
Publicado: (2016)

CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies
por: Zona, Laetitia, et al.
Publicado: (2014)

Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C
por: Xiao, Fei, et al.
Publicado: (2015)

Hepatitis C virus infection and related liver disease: the quest for the best animal model
por: Mailly, Laurent, et al.
Publicado: (2013)

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes
por: Verrier, Eloi R., et al.
Publicado: (2016)

P.068 Use of a respiratory virus panel test for the diagnosis of viral respiratory infections: impact of rhinoviruses
por: Stoll-Keller, F., et al.
Publicado: (2009)

Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design
por: Keck, Zhen-Yong, et al.
Publicado: (2019)

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2022)

Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant
por: Benotmane, Ilies, et al.
Publicado: (2022)

New perspectives for preventing hepatitis C virus liver graft infection
por: Felmlee, Daniel J., et al.
Publicado: (2016)

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
por: Wrensch, Florian, et al.
Publicado: (2018)

Antigen specificities of HIV-infected cells: A role in infection and persistence?
por: Faua, Clayton, et al.
Publicado: (2023)

Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets
por: Verrier, Eloi R, et al.
Publicado: (2020)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

VIRO-01 - Intérêt du test de diagnostic des virus respiratoires par PCR multiplex.
por: Martin, C., et al.
Publicado: (2016)

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
por: Fournier, Carole, et al.
Publicado: (2007)

Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Zeisel, Mirjam B., et al.
Publicado: (2021)

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
por: Charmetant, Xavier, et al.
Publicado: (2022)

Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein E
por: Lefèvre, Mathieu, et al.
Publicado: (2014)

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Molecular evolution of the SARS-CoV-2 omicron BA.2 variant in kidney transplant recipients with prolonged viral shedding
por: Caillard, Sophie, et al.
Publicado: (2023)

Clearance of persistent hepatitis C virus infection using a claudin-1-targeting monoclonal antibody
por: Mailly, Laurent, et al.
Publicado: (2015)

Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors
por: Bitzegeio, Julia, et al.
Publicado: (2010)

Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process
por: Colpitts, Che C., et al.
Publicado: (2020)

Neutralizing Antibody Response to Hepatitis C Virus
por: Wang, Yong, et al.
Publicado: (2011)

Hepatitis B virus compartmentalization and single-cell differentiation in hepatocellular carcinoma
por: Jühling, Frank, et al.
Publicado: (2021)

Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients
por: Gallais, Floriane, et al.
Publicado: (2022)

Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma
por: Plissonnier, Marie-Laure, et al.
Publicado: (2018)

Hepatitis E virus neutralization by porcine serum antibodies
por: Gremmel, Nele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8aqun9k94v8seqhd8lacbjg7l3